| MeSH term | MeSH ID | Detail |
|---|---|---|
| Microvascular Angina | D017566 | 2 associated lipids |
| Carcinoma, Lobular | D018275 | 4 associated lipids |
| Chronic Disease | D002908 | 7 associated lipids |
| Leishmaniasis, Cutaneous | D016773 | 6 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Arthritis, Reactive | D016918 | 3 associated lipids |
| Carcinoid Heart Disease | D002275 | 1 associated lipids |
| Hyperphosphatemia | D054559 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Doumouchtsis K et al. | Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. | 2009 | Ther Apher Dial | pmid:19379170 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
| Kazama JJ et al. | Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism. | 2006 | Ther Apher Dial | pmid:16817791 |
| Rashtchizadeh N et al. | Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. | 2012 | Ther Apher Dial | pmid:23190522 |
| Dzgoeva FU et al. | [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. | 2014 | Ter. Arkh. | pmid:25095658 |
| Kochetkova EA et al. | [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. | 2010 | Ter. Arkh. | pmid:20873238 |
| Hazenberg JG et al. | Microdamage detection and repair in bone: fracture mechanics, histology, cell biology. | 2009 | Technol Health Care | pmid:19478407 |
| Suda T et al. | [Merger of bone biology and immunology]. | 2002 | Tanpakushitsu Kakusan Koso | pmid:12385106 |
| Straface G et al. | Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. | 2011 | Stroke | pmid:21903966 |
| Golledge J et al. | Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. | 2004 | Stroke | pmid:15143295 |